Filing Details
- Accession Number:
- 0001104659-17-019996
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-29 16:03:28
- Reporting Period:
- 2017-03-27
- Filing Date:
- 2017-03-29
- Accepted Time:
- 2017-03-29 16:03:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613859 | Pra Health Sciences Inc. | PRAH | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1297251 | W David Dockhorn | C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612 | Executive Vice President & Cco | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-27 | 55,574 | $2.94 | 55,574 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-03-27 | 55,574 | $62.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-03-27 | 29,608 | $11.73 | 29,608 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-03-27 | 29,608 | $62.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-27 | 55,574 | $0.00 | 55,574 | $2.94 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-27 | 29,608 | $0.00 | 29,608 | $11.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-12-21 | No | 4 | M | Direct | |
55,665 | 2023-12-20 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The options vested on September 23, 2013.
- 17,054 of the options vested on September 23, 2014; 12,554 of the options vested on September 23, 2015.